Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Recruiting

R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse

NCT05257018

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Dongmei Ji Shanghai, Shanghai Municipality, China

Cancer Hospital affilicaited to Xinjiang Medical University Ürümqi, Xinjiang, China

View Trial Details

Recruiting

Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma

NCT04512534

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Dongmei Ji Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Efficacy and Safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell Lymphoma

NCT07508605

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Shenzhen University General Hospital Shenzhen, Guangdong, China

View Trial Details

Recruiting

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

NCT06451497

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +58 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

NEXT Oncology Austin, TX 78758, Texas, United States

NEXT Oncology San Antonio, Texas, United States

View Trial Details

Recruiting

Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)

NCT07047885

Conditions: Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

Low Dose Epcoritamab Plus GemOx in R/R DLBCL

NCT07451652

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Hospital Universitario "Dr. José Eleuterio González" Monterrey, Nuevo León, Mexico

View Trial Details

Recruiting

DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)

NCT07059650

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Peking University Third Hospital Beijing, China

Hunan Cancer Hospital Changsha, China

West China Hospital of Sichuan University Chengdu, China

Guangdong Provincial People's Hospital Guangzhou, China

View all 13 locations

View Trial Details

Recruiting

Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL

NCT07234487

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: A.N.Bakulev Center for cardiovascular surgery of the Russian Ministry of Health Moscow, Russia

National Medical and Surgical Center named after N.I. Pirogov Moscow, Russia

St. Petersburg State Pavlov Medical University Saint Petersburg, Russia

View Trial Details

Recruiting

Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL

NCT06104592

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

NCT06144606

Conditions: Acute Lymphoblastic Leukemia, B-Cell Lymphoblastic Leukemia, Burkitt Lymphoma, +20 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions